Exchange: OTC·Updated 03:58 PM EDT

EMMLD OKYO Pharma Limited

$1.38
$0.02
(1.43%)
Today
Mkt Cap$73.47M
Vol126,873.00

About EMMLD

OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
50

Sentiment

How do you feel about EMMLD?

Advertisement|Remove ads.